NeuroMetrix Valuation

NURO Stock  USD 4.16  0.16  4.00%   
At this time, the firm appears to be undervalued. NeuroMetrix secures a last-minute Real Value of $15.4 per share. The latest price of the firm is $4.16. Our model forecasts the value of NeuroMetrix from analyzing the firm fundamentals such as Profit Margin of (1.11) %, current valuation of (9.49 M), and Return On Equity of -0.3 as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend obtaining undervalued stocks and abandoning overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Price Book
0.4113
Enterprise Value
-9.5 M
Enterprise Value Ebitda
1.3377
Price Sales
1.4003
Enterprise Value Revenue
0.245
Undervalued
Today
4.16
Please note that NeuroMetrix's price fluctuation is somewhat reliable at this time. Calculation of the real value of NeuroMetrix is based on 3 months time horizon. Increasing NeuroMetrix's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for NeuroMetrix is useful when determining the fair value of the NeuroMetrix stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of NeuroMetrix. Since NeuroMetrix is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NeuroMetrix Stock. However, NeuroMetrix's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  4.16 Real  15.4 Target  50.0 Hype  4.26 Naive  4.15
The real value of NeuroMetrix Stock, also known as its intrinsic value, is the underlying worth of NeuroMetrix Company, which is reflected in its stock price. It is based on NeuroMetrix's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of NeuroMetrix's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence NeuroMetrix's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
15.40
Real Value
19.84
Upside
Estimating the potential upside or downside of NeuroMetrix helps investors to forecast how NeuroMetrix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NeuroMetrix more accurately as focusing exclusively on NeuroMetrix's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.214.268.70
Details
Naive
Forecast
LowNext ValueHigh
0.084.158.60
Details
0 Analysts
Consensus
LowTarget PriceHigh
45.5050.0055.50
Details

NeuroMetrix Investments

3.26 Million

NeuroMetrix Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining NeuroMetrix's current stock value. Our valuation model uses many indicators to compare NeuroMetrix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NeuroMetrix competition to find correlations between indicators driving NeuroMetrix's intrinsic value. More Info.
NeuroMetrix is rated below average in price to book category among related companies. It is regarded fourth in price to earning category among related companies reporting about  15.83  of Price To Earning per Price To Book. . Comparative valuation analysis is a catch-all model that can be used if you cannot value NeuroMetrix by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for NeuroMetrix's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NeuroMetrix's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates NeuroMetrix's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in NeuroMetrix and how it compares across the competition.

About NeuroMetrix Valuation

The stock valuation mechanism determines the current worth of NeuroMetrix on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of NeuroMetrix. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of NeuroMetrix based exclusively on its fundamental and basic technical indicators. By analyzing NeuroMetrix's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of NeuroMetrix's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of NeuroMetrix. We calculate exposure to NeuroMetrix's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to NeuroMetrix's related companies.
Last ReportedProjected for 2024
Gross Profit3.9 M3.8 M
Pretax Profit Margin(1.11)(1.16)
Operating Profit Margin(1.21)(1.27)
Net Loss(1.11)(1.16)
Gross Profit Margin 0.67  0.66 

8 Steps to conduct NeuroMetrix's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates NeuroMetrix's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct NeuroMetrix's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain NeuroMetrix's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine NeuroMetrix's revenue streams: Identify NeuroMetrix's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research NeuroMetrix's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish NeuroMetrix's growth potential: Evaluate NeuroMetrix's management, business model, and growth potential.
  • Determine NeuroMetrix's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate NeuroMetrix's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

NeuroMetrix Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as NeuroMetrix does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares OutstandingM

NeuroMetrix Current Valuation Indicators

Valuation refers to the process of determining the present value of NeuroMetrix and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value NeuroMetrix we look at many different elements of the entity such as NeuroMetrix's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. NeuroMetrix's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final NeuroMetrix's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as NeuroMetrix, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use NeuroMetrix's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes NeuroMetrix's worth.
When determining whether NeuroMetrix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NeuroMetrix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neurometrix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neurometrix Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for NeuroMetrix Stock analysis

When running NeuroMetrix's price analysis, check to measure NeuroMetrix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuroMetrix is operating at the current time. Most of NeuroMetrix's value examination focuses on studying past and present price action to predict the probability of NeuroMetrix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuroMetrix's price. Additionally, you may evaluate how the addition of NeuroMetrix to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Is NeuroMetrix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuroMetrix. If investors know NeuroMetrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuroMetrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.27)
Revenue Per Share
5.664
Quarterly Revenue Growth
(0.29)
Return On Assets
(0.19)
Return On Equity
(0.30)
The market value of NeuroMetrix is measured differently than its book value, which is the value of NeuroMetrix that is recorded on the company's balance sheet. Investors also form their own opinion of NeuroMetrix's value that differs from its market value or its book value, called intrinsic value, which is NeuroMetrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuroMetrix's market value can be influenced by many factors that don't directly affect NeuroMetrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeuroMetrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuroMetrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuroMetrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.